Human Placental Extract and its Formulations is back in India vide the Gazette Notification No. G.S.R 418(E) dated May 30, 2011 - the Ministry of Health & Family Welfare...... USE OF PLACENTREX CONTINUES!
Related Posts Plugin for WordPress, Blogger...

Saturday, April 2, 2011

Madras High Court postpones hearing on banned drugs case to April 18, 2011


Courtsey: Ramesh Shankar, Mumbai, Saturday, April 02, 2011, 08:00 Hrs  [IST]
The Madras High Court has postponed the hearing on the interim stay of the  court dated March 15 in which it had allowed 15 days time to the drug companies to liquidate the stocks of nimesulide suspension and Phenylpropanolamine (PPA), which were banned in the country on February 10 this year by the union health ministry along with some other drugs. The next hearing on the issue will be held on April 18.
The court decided to postpone the hearing as the respondents, the health ministry and the DCGI, did not appear in the court on March 31.  The postponement of the hearing of the case will give more time, at least till April 18, to the drug companies to liquidate their stocks of these banned drugs. A petition on this issue was filed by Confederation of Indian Pharmaceutical Industries (CIPI), an association of thousands of small pharma companies in the country. 

In another significant development, the court has merged this CIPI case with another similar case filed by pharma major Cipla Ltd on March 23.

Hearing the petition filed by Cipla on March 23, the Madras High court had stayed the entire notification of the ministry (GSR 82 E) dated February 10, 2011 in which it had banned six of the most controversial drugs in the country with immediate effect. These drugs included the non-steroid anti-inflammatory drug nimesulide (below 12 years age), gastroprokinetic agent Cisapride, decongestant drug Phenylpropanolamine (PPA), human placenta extracts, Sibutramine & its formulations and R-Sibutramine & its formulations.

No comments:

Post a Comment